239 related articles for article (PubMed ID: 28863123)
1. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
Uslu-Beşli L; Kabasakal L; Sağer S; Cicik E; Asa S; Sönmezoğlu K
Nucl Med Commun; 2017 Nov; 38(11):964-970. PubMed ID: 28863123
[TBL] [Abstract][Full Text] [Related]
2. Orbital positron emission tomography/computed tomography (PET/CT) imaging findings in Graves ophthalmopathy.
García-Rojas L; Adame-Ocampo G; Mendoza-Vázquez G; Alexánderson E; Tovilla-Canales JL
BMC Res Notes; 2013 Sep; 6():353. PubMed ID: 24007404
[TBL] [Abstract][Full Text] [Related]
3. [F-qi-FDG PET of the thyroid gland in Graves' disease].
Börner AR; Voth E; Wienhard K; Wagner R; Schicha H
Nuklearmedizin; 1998; 37(7):227-33. PubMed ID: 9830612
[TBL] [Abstract][Full Text] [Related]
4. Quantitative CT of the orbit in Graves' disease.
Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I
Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341
[TBL] [Abstract][Full Text] [Related]
5. Elevated 18F-FDG uptake in skeletal muscles and thymus: a clue for the diagnosis of Graves' disease.
Chen YK; Chen YL; Liao AC; Shen YY; Kao CH
Nucl Med Commun; 2004 Feb; 25(2):115-21. PubMed ID: 15154698
[TBL] [Abstract][Full Text] [Related]
6. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography.
Boerner AR; Voth E; Theissen P; Wienhard K; Wagner R; Schicha H
Thyroid; 1998 Sep; 8(9):765-72. PubMed ID: 9777746
[TBL] [Abstract][Full Text] [Related]
7. Current imaging methods for assessing Graves` orbitopathy activity with particular emphasis on FDG-PET.
Ochmann A; Winder M; Nalewajka-Kołodziejczak J; Chudek J
Front Endocrinol (Lausanne); 2023; 14():1138569. PubMed ID: 37600686
[TBL] [Abstract][Full Text] [Related]
8. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
9. Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism.
Manso PG; Furlanetto RP; Wolosker AM; Paiva ER; de Abreu MT; Maciel RM
Thyroid; 1998 Jan; 8(1):49-52. PubMed ID: 9492153
[TBL] [Abstract][Full Text] [Related]
10. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
[TBL] [Abstract][Full Text] [Related]
11. 18 F-FDG-PET/MRI in patients with Graves' orbitopathy.
Weber M; Deuschl C; Bechrakis N; Umutlu L; Antoch G; Eckstein A; Binse I; Oeverhaus M
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3107-3117. PubMed ID: 34406498
[TBL] [Abstract][Full Text] [Related]
12. [Sonography of the retrobulbar space in autoimmune hyperthyroidism of the Basedow type].
Schillings S; Wagner J; Franzen W; Wildmeister W
Z Gesamte Inn Med; 1990 Nov; 45(22):678-83. PubMed ID: 2099028
[TBL] [Abstract][Full Text] [Related]
13. Imaging of disease activity in Graves' orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores.
Galuska L; Leovey A; Szucs-Farkas Z; Szabados L; Garai I; Berta A; Balazs E; Varga J; Nagy EV
Nucl Med Commun; 2005 May; 26(5):407-14. PubMed ID: 15838422
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography in Graves' ophthalmopathy.
Enzmann D; Marshal WH; Rosenthal AR; Kriss JP
Radiology; 1976 Mar; 118(3):615-20. PubMed ID: 946330
[TBL] [Abstract][Full Text] [Related]
15. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
[TBL] [Abstract][Full Text] [Related]
16. Graves' orbitopathy: current imaging procedures.
Kirsch E; Hammer B; von Arx G
Swiss Med Wkly; 2009 Oct; 139(43-44):618-23. PubMed ID: 19950023
[TBL] [Abstract][Full Text] [Related]
17. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease.
Trokel SL; Jakobiec FA
Ophthalmology; 1981 Jun; 88(6):553-64. PubMed ID: 6894976
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic trinity: Graves' disease on F-18 FDG PET.
Chen YK; Wang YF; Chiu JS
Clin Nucl Med; 2007 Oct; 32(10):816-7. PubMed ID: 17885368
[TBL] [Abstract][Full Text] [Related]
19. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
